Skip to main content

Table 2 Biological parameters evolution between day 0 and day 7

From: Multicentre study evaluating the non-inferiority of the new paediatric formulation of artesunate/amodiaquine versus artemether/lumefantrine for the management of uncomplicated Plasmodium falciparum malaria in children in Cameroon, Ivory Coast and Senegal

Parameters AS-AQ   AL  
  D0 D7 p D0 D7 p
Mean Hb level (g/dl) 9,5 ± 2 9.3 ± 1.5 0.75 10 ± 2 9.6 ±16 0.63
Anemia 71,9 87,1 <10-3 66,4 78,9 0,002
(Hb < 11g/dl) (%)
Patient with abnormal 8.4 4.4 0,05 7.3 6 0.25
ALAT (<40 UI/L) (%)
Patient with abnormal 30.1 10 <10-3 27.6 12.9 <10-3
ASAT (<40 UI/L) (%)
Mean bilirubine level 11.2 ±8.5 7.3 ±3.6 0.58 11.8 ± 11.4 7.4 ±3.4 0.55
Mean Creatinin level 5.8 ±2.4 5.9 ±2.5 0.99 6 ±2.2 5.8 ± 2.3 0.85